Blog
Elliott Wave Journal: Market Structure, Trends & Trade Ideas
Professional Elliott Wave insights, charts, and forecasts to guide your trading decisions.
Robinhood (NASDAQ: HOOD) Enters Wave (III) Final Stage
Robinhood (NASDAQ: HOOD) rallied more than 300% since April 2025 breaking into new all time highs. In our previous article, we explained the bullish sequence taking place within the weekly cycle leading…
Platinum (PL) Price Soars in Strong Uptrend
Platinum (PL) shows a bullish sequence from March 2020 low, confirming the right side is higher. In this article, we will explore the latest long-term Elliott Wave technical outlook. Platinum…
TXN Elliott Wave View: Dip Approaches Blue Box Buying Zone
After it completed a 55% rally from April 2025 to July 2025, TXN is correcting the impulse rally. At the extreme of the current pullback, buyers can find new entry.…
Solana (SOLUSD) Analysis – How We Navigate Using Elliott Wave Analysis
Hello traders. Welcome to a new blog post where we discuss trade setups in the recent times. In this post, the spotlight will be on Solana - a cryptocurrency. Solana…
CRWD in Final Stage: One More High Could Trigger Market Correction
CrowdStrike (CRWD) leads AI-powered cybersecurity with strong financial results and growing market presence. By mid-2025, its market value passed $104 billion. This shows investor trust, even with ongoing net losses.…
Dow Futures (YM) Resumes Upward Drive in Impulsive Formation
The short-term Elliott Wave analysis for Dow Futures (YM) indicates a cycle from the 1 August 2025 low is forming an impulse. The wave 1 peaked at 45,841, followed by…
Elliott Wave Analysis: USDJPY Zigzag Correction Likely to Fail Below 149
The short-term Elliott Wave analysis for USDJPY indicates that the decline from the August 1, 2025, high is developing as a double three Elliott Wave structure. From that peak, wave…
SPY Elliott Wave Outlook: Wave (3) Nearing Termination
The short-term Elliott Wave outlook for the S&P 500 ETF (SPY) highlights a cycle starting from the August 1 low. This cycle is unfolding as a diagonal and nears completion.…
Biotech Surge: XBI Ends Correction and Rallies as Expected
The SPDR S&P Biotech ETF (XBI) draws investors who seek high-risk, high-reward exposure to the biotech sector. In late 2025, investor sentiment remains cautiously optimistic. This reflects both strong opportunities…
